Table 2.
Tracking Strategy |
Which T cells are alloreactive |
Animal Models |
Human Studies |
Allorecognition pathways detected |
Advantages | Disadvantages | References |
---|---|---|---|---|---|---|---|
| |||||||
In vitro restimulation: MLR | Cells expressing surface markers of activation and proliferation by flow cytometry | ✓ | ✓ | Direct and indirect* | Simple preparation and readout | In vitro stimulation differs from in vivo stimulation conditions | 11,14,20,25 |
Cells with diluted CFSE following CFSE labeling | Allows study of polyclonal response to alloantigen | Does not reflect effects of immunosuppression | |||||
IFNy-producing cells by cytokine flow cytometry | Surface markers can be detected within 24 hours of stimulation | CFSE dilution requires ≥48 hours for detection | |||||
| |||||||
In vitro restimulation: IFNy ELISpot | IFNy-secreting cells | ✓ | ✓ | Direct and indirect* | Simple preparation and readout | In vitro stimulation differs from in vivo stimulation conditions | 10–12 |
Allows study of polyclonal response to alloantigen | Does not reflect effects of immunosuppression | ||||||
More sensitive than intracellular IFNy detection by flow cytometry | Underreporting in samples with many IFNy-producing cells | ||||||
| |||||||
Trans-vivo DTH | Cells expressing surface markers of activation and proliferation by flow cytometry | ✓ | ✓ | Indirect | Allows study of polyclonal response to alloantigen | Does not fully recapitulate allograft rejection processes | 31,32 |
Cells with diluted CFSE following CFSE labeling | Includes influence of factors produced by local cells and other nuances of in vivo stimulation | Does not reflect effects of immunosuppression | |||||
Labor intensive and requires careful assessment of footpad swelling | |||||||
IFNy producing cells by cytokine flow cytometry | Surface markers can be detected within 24 hours of stimulation | CFSE dilution requires ≥48 hours for detection | |||||
| |||||||
Transgenic TCR | Tg or Rg mouse-derived T cells labeled by CFSE, transgenic fluorescent marker or congenic marker | ✓ | Direct or indirect | Allows analysis of naïve or antigen-experienced allospecific T cells | Single TCR is not reflective of a polyclonal response | 23,33 | |
Allows control of precursor frequency by adoptive transfer | Generation of new TCR-Tg mice is slow | ||||||
|
|
||||||
Retrogenic TCR** | ✓ | Direct or indirect | Faster than generation of TCR-Tg mice | Single TCR is not reflective of a polyclonal response | 116 | ||
| |||||||
pMHC Multimer | Multimer-bound T cells | ✓ | ✓ | Direct or indirect | Allows study of a polyclonal response to a single alloantigen specificity | Requires knowledge of allopeptide identity | 42,43,50,52 |
Multimer binding to TCR impacts T cell function | |||||||
|
|
||||||
pMHC Streptamer** | ✓ | ✓ | Direct or indirect | Lower impact of TCR binding on T cell function than traditional pMHC multimers; allows functional analysis after sorting | Requires knowledge of allopeptide identify | 56 | |
More costly and difficult to prepare than traditional pMHC multimers |
In cultures containing host and donor PBMCs, donor or recipient PBMCs can theoretically present alloantigen, although direct responses may predominate. If donor PBMCs are lysed prior to coculture, only PBMCs from the recipient will contain intact antigen-presenting cells and all allopresentation will occur through the indirect pathway.
Application of the technique for this purpose has not been reported. However, pMHC Streptamers are structurally and functionally like pMHC multimers and TCR-Rgs are like TCR-Tgs such that many of the applications of TCR-Tgs and pMHC multimers should be possible using TCR-Rgs and pMHC Streptamers, respectively.